- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Contact us
- Thank you
Installation of the first XPS™ in Asia
Strategic collaborations between University Hospitals in Kazakhstan with prestigious Universities in the U.S. and Europe have resulted in unique collaborations to improve health care quality through exchange of knowledge and skills in a variety of areas, including lung transplantation. Lung transplantation is the only therapeutic option for selected patients suffering from end stage lung diseases. Earlier this year, Kazakhstan Vice-Minister of Healthcare Erik Baizhunussov, announced that the first lung transplantation will be made in Kazakhstan in 2014.
“We are ready for this type of transplantation. There are many patients who need this surgery as no other kind of surgery can save them. I think that we will be able to begin this surgery in 2014,” said Mr Baizhunussov.
At present, Asia accounts for less than five percent of the total number of lung transplants carried out in the world, but with increased economic opportunities, the number of lung transplants may increase. In instituting the STEEN Solution™ method with XPS™ early in these markets, this development can occur more rapidly than would otherwise be possible.
“It is a great pleasure to note that the XPS™ will be used to support the establishment of a new clinical program for lung transplantation in Asia. This is a great step forward to establish EVLP throughout the globe”, says Mr Christer de Flon, Marketing & Sales Director, XVIVO Perfusion.
September 30, 2014
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 31 788 21 59, email@example.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
The information was submitted for publication on September 30, 2014 at 2:30 p.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.